Medicina, Dermatología y Toxicología
Departamento
![Foto de Medicina, Dermatología y Toxicología](/img/noimage.png)
![Foto de University of Groningen](/img/noimage_org.png)
University of Groningen
Groninga, HolandaPublicaciones en colaboración con investigadores/as de University of Groningen (22)
2024
-
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale
American Heart Journal, Vol. 270, pp. 86-94
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement
Frontiers in Cardiovascular Medicine, Vol. 10
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1856-1864
-
Association of obesity with 3-month mortality in kidney failure patients with COVID-19
Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1348-1360
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19
Transplantation, Vol. 106, Núm. 5, pp. 1012-1023
-
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum
Clinical journal of the American Society of Nephrology : CJASN
-
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 5, pp. 994-999
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
COVID-19-related mortality in kidney transplant and haemodialysis patients: A comparative, prospective registry-based study
Nephrology Dialysis Transplantation, Vol. 36, Núm. 11, pp. 2094-2105
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
2020
-
COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983
2019
-
Immune-unreactive urinary albumin as a predictor of cardiovascular events: The Hortega Study
Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 633-641
2015
-
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Economics Review, Vol. 5, Núm. 1
-
Effect of a high-protein diet on maintenance of blood pressure levels achieved after initial weight loss: The DiOGenes randomized study
Journal of Human Hypertension, Vol. 29, Núm. 1, pp. 58-63
2013
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503